Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Kyzific 40mg Tablet
Manufacturer/Marketed By : NOVARTIS INDIA LTD
$2410.29 $2121.06
Kyzific 40mg tablet contains the active substance Asciminib. It is an anticancer medicine that belongs to the class tyrosine kinase receptor inhibitors. Kyzific 40mg tablet is used to treat a...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ASCIMINIB
Active Pharmaceutical Ingredient
Kyzific 40mg Tablet
2 410,29$
2 121,06$
Kyzific 40mg tablet contains the active substance Asciminib. It is an anticancer medicine that belongs to the class tyrosine kinase receptor inhibitors. Kyzific 40mg tablet is used to treat a certain type of chronic myeloid leukaemia (CML; a type of cancer of the white blood cells) in a chronic phase (CP) who have been previously treated with two or more tyrosine kinase inhibitors. It works by inhibiting the BCR-ABL1 tyrosine kinase, a fusion protein resulting from the Philadelphia chromosome translocation in chronic myeloid leukaemia (CML). It binds specifically to the myristoyl pocket of the ABL1 domain within the BCR-ABL1 protein, inducing a conformational change that locks the protein in an inactive state and inhibits its oncogenic activity. Inform your doctor before starting treatment with Kyzific 40mg tablet, as it may cause blood problems such as low platelet and white blood cell counts, pancreatic issues, and high blood pressure. Make sure to inform your physician of all the medicines you are taking before you start the treatment with this medication. Report any symptoms of difficulty breathing together with a cough or fever, chest pain, fever, weakness, or seizures.
Active Pharmaceutical Ingredient
Uses
• To treat a certain type of chronic myeloid leukaemia (CML; a type of cancer of the white blood cells) in a chronic phase (CP) who have been previously treated with two or more tyrosine kinase inhibitors.
Benefits
Kyzific works by binding specifically to the myristoyl pocket of the ABL1 domain within the BCR-ABL1 protein, inducing a conformational change that locks the protein in an inactive state and inhibits its oncogenic activity.
Side Effects
Like all medications, Kyzific 40 mg tablet can cause side effects, although not everyone who takes it will experience them.
Most Common Side Effects
• Trouble breathing or swallowing
• Swelling of the face, lips, or tongue
• Fever
• Skin rash or flushing of your skin
• Fast heartbeat
• Severe Pancreatitis
Common Side Effects
• Upper respiratory tract infection
• Headache and nausea
• Tiredness
• Rashes
• Muscle, bone or joint pain
• Diarrhea
How To Use
Take Kyzific 40mg tablet exactly as your doctor tells you. Do not change your dose or schedule or stop taking Kyzific 40mg tablet unless your healthcare provider tells you to. Take Kyzific 40mg tablet without food.
Safety Advice
• Breast Feeding: Don’t breastfeed while taking kyzific 40mg tablet and for 1 week after your last dose because the drug may come through into your breast milk.
• Alcohol: It is not known whether it is safe to use kyzific 40mg Tablet while consuming alcohol. Consult the doctor before taking this medication.
• Liver: You need to tell your doctor if you have any liver disorders before taking kyzific 40mg tablet. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.
• Lungs: Before starting treatment with Kyzific 40mg tablet, talk to your doctor if you have any lung conditions.
• Driving: kyzific 40mg Tablet is not likely to affect driving and the use of any tools or machines. Consult the doctor before taking this medication.
• Pregnancy: Kyzific 40mg tablet is not safe for use during pregnancy because it can harm the developing baby.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.